CRIS · Curis Inc
$4.83
+0.14 (+2.99%)
At close · Jul 28
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has concluded there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the Condensed Consolidated Financial Statements are issued.”View the 10-Q filed May 13, 2026
Market Cap
$188.27M
Shares
38.98M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jonathan Zung | Chief Development Officer | $882,415 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Diantha Duvall | CFO | $786,109 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James Dentzer | CEO | $3,390,187 |
| William E. Steinkrauss | CFO | $1,899,445 |
| Robert Martell | Head of R&D | $1,502,517 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| James Dentzer | CEO | $1,672,849 |
| Robert Martell | Head of R&D | $961,345 |
| William E. Steinkrauss | CFO | $891,755 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| James Dentzer | CEO | $1,557,773 |
| Robert Martell | Head of R&D | $776,494 |
| William E. Steinkrauss | CFO | $690,165 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| James Dentzer | CEO | $1,964,736 |
| Robert Martell | Head of R&D | $940,469 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| James Dentzer | CEO | $1,578,961 |